Abivax S.A.
Abivax S.A.（ABVX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
abvx · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$175
Consensus
$131
+29.2% upside
Low
$90.00
Median: $135 · Last Close: $101.53
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$131.22
29.2% upside
High Target
$175
72.4%
Low Target
$90
-11.4%
Current Price
$101.53
as of today
Based on analyst price targets, the ABVX stock price prediction for the next 12 months ranges from $90 to $175. The consensus ABVX price forecast of $131.22 implies 29.2% upside from the current price of $101.53.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $101.53 | ↑ 0.00% |
1-day model range: $98.37–$104.69. Peak: $104.69 (+0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ABVX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | Truist Securities | Maintains | Buy→Buy |
| 2026-06-02 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2026-06-02 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-06-02 | Wedbush | Upgrade ↑ | Underperform→Neutral |
| 2026-06-02 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-06-02 | BTIG | Maintains | Buy→Buy |
| 2026-05-26 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-24 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-25 | BTIG | Maintains | Buy→Buy |
| 2026-01-09 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Abivax S.A. (ABVX) stock. Of the recent 27 rating actions, 2 were upgrades and 1 were downgrades. 12 analysts currently cover ABVX.
分析师推荐趋势
ABVX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$71M
↓ 84.5% YoY
Revenue Next Year
$114M
↑ 61.5% YoY
EPS This Year
$-3.43
EPS Next Year
$-3.05
↓ 11.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast ABVX EPS of $-3.43 for the current fiscal year, based on estimates from 4 analysts. The ABVX revenue forecast is $71M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ABVX 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ABVX 的共识目标价为 $131.22（+29.2% 上行空间），分析师共识为 Buy。
ABVX 的短期预测（明日）为 $101.53（+0.00%）。
Abivax S.A. 在 NASDAQ 上市，代码 ABVX。ABVX 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
ABVX 预测 · 8 个问题根据 12 位华尔街分析师，ABVX 的 12 个月平均目标价为 $131.22，最高 $175.00、最低 $90.00。若有图表，中位目标价可在上方查看。相对当前价 $101.53，隐含约 +29.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.